Shire faces reverse-payment lawsuit over ADHD medication
An independent South Carolina pharmacy has filed a class action complaint against Shire for entering into an agreement with Actavis to allegedly keep a generic version of its brand-name attention deficit hyperactivity disorder medication off the market.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10